U.S. Reaches Deal for Nearly 600 Million Doses of COVID-19 Vaccine
WEDNESDAY, July 22, 2020 -- A nearly $2 billion contract with pharmaceutical company Pfizer and a German biotechnology firm will provide the United States with up to 600 million doses of a COVID-19 vaccine being developed by the companies, the U.S....
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Contracts | COVID-19 | Germany Health | Pfizer | Pharmaceuticals | USA Health | Vaccines